Abstract
The novel coumarin-based 'turn-on' fluorescent probe (E)-3-(2,5- dimethoxybenzylideneamino)-7-hydroxy-2H-chromen-2-one (MGM) was designed, synthesized, and characterized. This compound shows high selectivity for Cu +2, combined with a large fluorescence enhancement upon binding to Cu 2+. Benesi-Hildebrand and Job plots demonstrate that the stoichiometry of the Cu 2+ complex formed is 2:1. Preliminary studies employing epifluorescence microscopy demonstrated that Cu +2 could be imaged in human neuroblastoma SH-SY5Y cells treated with MGM.
Original language | English |
---|---|
Pages (from-to) | 5280-5283 |
Number of pages | 4 |
Journal | Tetrahedron Letters |
Volume | 53 |
Issue number | 39 |
DOIs | |
Publication status | Published - Sept 26 2012 |
Bibliographical note
Funding Information:This work was supported by the Millennium Scientific Initiative (Grant P05-001-F) and by the Instituto Nacional de Ciência e Tecnologia do Meio Ambiente-USP (Brazil). JCNF thanks the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for a Visiting Professor Fellowship. FHQ and LCF acknowledge fellowship support from the CNPq-Brazil.
Funding
This work was supported by the Millennium Scientific Initiative (Grant P05-001-F) and by the Instituto Nacional de Ciência e Tecnologia do Meio Ambiente-USP (Brazil). JCNF thanks the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for a Visiting Professor Fellowship. FHQ and LCF acknowledge fellowship support from the CNPq-Brazil.
Funders | Funder number |
---|---|
CNPq-Brazil | |
Instituto Nacional de Ciência e Tecnologia do Meio Ambiente-USP | |
Fundação de Amparo à Pesquisa do Estado de São Paulo |
ASJC Scopus Subject Areas
- Biochemistry
- Drug Discovery
- Organic Chemistry